 | • レポートコード：20QY06-00876 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、インターフェロンのグローバル市場について種類別（長持ちタイプ、普通タイプ）、用途別（肝炎、多発性硬化症、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・インターフェロン市場の概要 ・世界の主要地域別インターフェロン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のインターフェロン市場規模2015-2026：種類別（長持ちタイプ、普通タイプ） ・世界のインターフェロン市場規模2015-2026：用途別（肝炎、多発性硬化症、その他） ・インターフェロンの北米市場規模2015-2020 ・インターフェロンのヨーロッパ市場規模2015-2020 ・インターフェロンの中国市場規模2015-2020 ・インターフェロンの日本市場規模2015-2020 ・インターフェロンの東南アジア市場規模2015-2020 ・インターフェロンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Roche、Anke Biotechnology、Bayer、Merck & Co、Tri-Prime、Kawin、Genzon Pharma、Novartis、Biogen、Merck KGaA、Zydus Cadila、Huaxin Biotechnology、Harbin Pharmaceutical） ・インターフェロンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・インターフェロンの市場動向・機会・課題 ・調査の結論 |
Interferons (IFNs) are a group of signaling proteins made and released by host cells in response to the presence of several pathogens, such as viruses, bacteria, parasites, and also tumor cells. In a typical scenario, a virus-infected cell will release interferons causing nearby cells to heighten their anti-viral defenses.
Market Analysis and Insights: Global Interferon Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Interferon market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Interferon industry.
Based on our recent survey, we have several different scenarios about the Interferon YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Interferon will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Interferon Scope and Market Size
The global Interferon market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Interferon market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Interferon market is segmented into
Long-lasting Type
Ordinary Type
Segment by Application, the Interferon market is segmented into
Hepatitis
Multiple Sclerosis
Others
The Interferon market is analysed and market size information is provided by regions (countries). Segment by Application, the Interferon market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Interferon Market Share Analysis
Interferon market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Interferon business, the date to enter into the Interferon market, Interferon product introduction, recent developments, etc.
The major vendors covered:
Roche
Anke Biotechnology
Bayer
Merck & Co
Tri-Prime
Kawin
Genzon Pharma
Novartis
Biogen
Merck KGaA
Zydus Cadila
Huaxin Biotechnology
Harbin Pharmaceutical
1 Interferon Market Overview
1.1 Interferon Product Scope
1.2 Interferon Segment by Type
1.2.1 Global Interferon Sales by Type (2020-2026)
1.2.2 Long-lasting Type
1.2.3 Ordinary Type
1.3 Interferon Segment by Application
1.3.1 Global Interferon Sales Comparison by Application (2020-2026)
1.3.2 Hepatitis
1.3.3 Multiple Sclerosis
1.3.4 Others
1.4 Interferon Market Estimates and Forecasts (2015-2026)
1.4.1 Global Interferon Sales Growth Rate (2015-2026)
1.4.2 Global Interferon Revenue and Growth Rate (2015-2026)
1.4.3 Global Interferon Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Interferon Industry Impact
1.5.1 How the Covid-19 is Affecting the Interferon Industry
1.5.1.1 Interferon Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Interferon Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Interferon Players to Combat Covid-19 Impact
2 Interferon Estimate and Forecast by Region
2.1 Global Interferon Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Interferon Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Interferon Sales Market Share by Region (2015-2020)
2.2.2 Global Interferon Revenue Market Share by Region (2015-2020)
2.3 Global Interferon Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Interferon Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Interferon Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Interferon Estimates and Projections (2015-2026)
2.4.2 Europe Interferon Estimates and Projections (2015-2026)
2.4.3 China Interferon Estimates and Projections (2015-2026)
2.4.4 Japan Interferon Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Interferon Estimates and Projections (2015-2026)
2.4.6 India Interferon Estimates and Projections (2015-2026)
3 Global Interferon Competition Landscape by Players
3.1 Global Top Interferon Players by Sales (2015-2020)
3.2 Global Top Interferon Players by Revenue (2015-2020)
3.3 Global Interferon Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interferon as of 2019)
3.4 Global Interferon Average Price by Company (2015-2020)
3.5 Manufacturers Interferon Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Interferon Players (Opinion Leaders)
4 Global Interferon Market Size by Type
4.1 Global Interferon Historic Market Review by Type (2015-2020)
4.1.1 Global Interferon Sales Market Share by Type (2015-2020)
4.1.2 Global Interferon Revenue Market Share by Type (2015-2020)
4.1.3 Global Interferon Price by Type (2014-2020)
4.2 Global Interferon Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Interferon Sales Forecast by Type (2021-2026)
4.2.2 Global Interferon Revenue Forecast by Type (2021-2026)
4.2.3 Global Interferon Price Forecast by Type (2021-2026)
5 Global Interferon Market Size by Application
5.1 Global Interferon Historic Market Review by Application (2015-2020)
5.1.1 Global Interferon Sales Market Share by Application (2015-2020)
5.1.2 Global Interferon Revenue Market Share by Application (2015-2020)
5.1.3 Global Interferon Price by Application (2015-2020)
5.2 Global Interferon Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Interferon Sales Forecast by Application (2021-2026)
5.2.2 Global Interferon Revenue Forecast by Application (2021-2026)
5.2.3 Global Interferon Price Forecast by Application (2021-2026)
3 North America Interferon Market Facts & Figures
3.2 North America Interferon Sales Market Share by Company (2015-2020)
3.3 North America Interferon Sales Market Share by Type (2015-2020)
3.4 North America Interferon Sales Market Share by Application (2015-2020)
4 Europe Interferon Market Facts & Figures
4.2 Europe Interferon Sales Market Share by Company (2015-2020)
4.3 Europe Interferon Sales Market Share by Type (2015-2020)
4.4 Europe Interferon Sales Market Share by Application (2015-2020)
5 China Interferon Market Facts & Figures
5.2 China Interferon Sales Market Share by Company (2015-2020)
5.3 China Interferon Sales Market Share by Type (2015-2020)
5.4 China Interferon Sales Market Share by Application (2015-2020)
6 Japan Interferon Market Facts & Figures
6.2 Japan Interferon Sales Market Share by Company (2015-2020)
6.3 Japan Interferon Sales Market Share by Type (2015-2020)
6.4 Japan Interferon Sales Market Share by Application (2015-2020)
7 Southeast Asia Interferon Market Facts & Figures
7.2 Southeast Asia Interferon Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Interferon Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Interferon Sales Market Share by Application (2015-2020)
8 India Interferon Market Facts & Figures
8.2 India Interferon Sales Market Share by Company (2015-2020)
8.3 India Interferon Sales Market Share by Type (2015-2020)
8.4 India Interferon Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Interferon Business
12.1 Roche
12.1.1 Roche Interferon Corporation Information
12.1.2 Roche Interferon Business Overview and Total Revenue
12.1.3 Roche Interferon Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Roche Interferon Products Offered
12.1.5 Roche Recent Development
12.2 Anke Biotechnology
12.2.1 Anke Biotechnology Interferon Corporation Information
12.2.2 Anke Biotechnology Interferon Business Overview and Total Revenue
12.2.3 Anke Biotechnology Interferon Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Anke Biotechnology Interferon Products Offered
12.2.5 Anke Biotechnology Recent Development
12.3 Bayer
12.3.1 Bayer Interferon Corporation Information
12.3.2 Bayer Interferon Business Overview and Total Revenue
12.3.3 Bayer Interferon Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bayer Interferon Products Offered
12.3.5 Bayer Recent Development
12.4 Merck & Co
12.4.1 Merck & Co Interferon Corporation Information
12.4.2 Merck & Co Interferon Business Overview and Total Revenue
12.4.3 Merck & Co Interferon Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Merck & Co Interferon Products Offered
12.4.5 Merck & Co Recent Development
12.5 Tri-Prime
12.5.1 Tri-Prime Interferon Corporation Information
12.5.2 Tri-Prime Interferon Business Overview and Total Revenue
12.5.3 Tri-Prime Interferon Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Tri-Prime Interferon Products Offered
12.5.5 Tri-Prime Recent Development
12.6 Kawin
12.6.1 Kawin Interferon Corporation Information
12.6.2 Kawin Interferon Business Overview and Total Revenue
12.6.3 Kawin Interferon Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Kawin Interferon Products Offered
12.6.5 Kawin Recent Development
12.7 Genzon Pharma
12.7.1 Genzon Pharma Interferon Corporation Information
12.7.2 Genzon Pharma Interferon Business Overview and Total Revenue
12.7.3 Genzon Pharma Interferon Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Genzon Pharma Interferon Products Offered
12.7.5 Genzon Pharma Recent Development
12.8 Novartis
12.8.1 Novartis Interferon Corporation Information
12.8.2 Novartis Interferon Business Overview and Total Revenue
12.8.3 Novartis Interferon Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Novartis Interferon Products Offered
12.8.5 Novartis Recent Development
12.9 Biogen
12.9.1 Biogen Interferon Corporation Information
12.9.2 Biogen Interferon Business Overview and Total Revenue
12.9.3 Biogen Interferon Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Biogen Interferon Products Offered
12.9.5 Biogen Recent Development
12.10 Merck KGaA
12.10.1 Merck KGaA Interferon Corporation Information
12.10.2 Merck KGaA Interferon Business Overview and Total Revenue
12.10.3 Merck KGaA Interferon Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Merck KGaA Interferon Products Offered
12.10.5 Merck KGaA Recent Development
12.11 Zydus Cadila
12.11.1 Zydus Cadila Interferon Corporation Information
12.11.2 Zydus Cadila Interferon Business Overview and Total Revenue
12.11.3 Zydus Cadila Interferon Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Zydus Cadila Interferon Products Offered
12.11.5 Zydus Cadila Recent Development
12.12 Huaxin Biotechnology
12.12.1 Huaxin Biotechnology Interferon Corporation Information
12.12.2 Huaxin Biotechnology Interferon Business Overview and Total Revenue
12.12.3 Huaxin Biotechnology Interferon Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Huaxin Biotechnology Interferon Products Offered
12.12.5 Huaxin Biotechnology Recent Development
12.13 Harbin Pharmaceutical
12.13.1 Harbin Pharmaceutical Interferon Corporation Information
12.13.2 Harbin Pharmaceutical Interferon Business Overview and Total Revenue
12.13.3 Harbin Pharmaceutical Interferon Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Harbin Pharmaceutical Interferon Products Offered
12.13.5 Harbin Pharmaceutical Recent Development
13 Interferon Manufacturing Cost Analysis
13.1 Interferon Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Interferon
13.4 Interferon Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Interferon Distributors List
14.3 Interferon Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Interferon Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Interferon Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Interferon Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Interferon Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Interferon Players to Combat Covid-19 Impact
Table 8. Global Market Interferon Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Interferon Sales (K Units) by Region (2015-2020)
Table 10. Global Interferon Sales Market Share by Region (2015-2020)
Table 11. Global Interferon Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Interferon Revenue Share by Region (2015-2020)
Table 13. Global Interferon Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Interferon Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Interferon Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Interferon Revenue Share Forecast by Region (2021-2026)
Table 17. Global Interferon (K Units) of Key Companies (2015-2020)
Table 18. Global Interferon Sales Share by Company (2015-2020)
Table 19. Global Interferon Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Interferon Revenue Share by Company (2015-2020)
Table 21. Global Interferon by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interferon as of 2019)
Table 22. Global Interferon Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Interferon Manufacturing Sites and Area Served
Table 24. Manufacturers Interferon Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Interferon Players
Table 27. Global Interferon Sales (K Units) by Type (2015-2020)
Table 28. Global Interferon Sales Share by Type (2015-2020)
Table 29. Global Interferon Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Interferon Price (K Units) by Type (2015-2020)
Table 31. Global Interferon Sales Share by Type (2021-2026)
Table 32. Global Interferon Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Interferon Revenue Share by Type (2021-2026)
Table 34. Global Interferon Price (K Units) by Type (2021-2026)
Table 35. Global Interferon Sales (K Units) by Application (2015-2020)
Table 36. Global Interferon Sales Share by Application (2015-2020)
Table 37. Global Interferon Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Interferon Price (K Units) by Application (2015-2020)
Table 39. Global Interferon Sales (K Units) by Application (2021-2026)
Table 40. Global Interferon Sales Share by Application (2021-2026)
Table 41. Global Interferon Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Interferon Revenue Share by Application (2021-2026)
Table 43. Global Interferon Price (K Units) by Application (2021-2026)
Table 44. United States Interferon Sales (K Units) by Company (2015-2020)
Table 45. United States Interferon Sales Market Share by Company (2015-2020)
Table 46. United States Interferon Sales (K Units) by Type (2015-2020)
Table 47. United States Interferon Sales Market Share by Type (2015-2020)
Table 48. United States Interferon Sales (K Units) by Application (2015-2020)
Table 49. United States Interferon Sales Market Share by Application (2015-2020)
Table 50. Europe Interferon Sales (K Units) by Company (2015-2020)
Table 51. Europe Interferon Sales Market Share by Company (2015-2020)
Table 52. Europe Interferon Sales (K Units) by Type (2015-2020)
Table 53. Europe Interferon Sales Market Share by Type (2015-2020)
Table 54. Europe Interferon Sales (K Units) by Application (2015-2020)
Table 55. Europe Interferon Sales Market Share by Type (2015-2020)
Table 56. China Interferon Sales (K Units) by Company (2015-2020)
Table 57. China Interferon Sales Market Share by Company (2015-2020)
Table 58. China Interferon Sales (K Units) by Type (2015-2020)
Table 59. China Interferon Sales Market Share by Type (2015-2020)
Table 60. China Interferon Sales (K Units) by Application (2015-2020)
Table 61. China Interferon Sales Market Share by Application (2015-2020)
Table 62. Japan Interferon Sales (K Units) by Company (2015-2020)
Table 63. Japan Interferon Sales Market Share by Company (2015-2020)
Table 64. Japan Interferon Sales (K Units) by Type (2015-2020)
Table 65. Japan Interferon Sales Market Share by Type (2015-2020)
Table 66. Japan Interferon Sales (K Units) by Application (2015-2020)
Table 67. Japan Interferon Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Interferon Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Interferon Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Interferon Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Interferon Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Interferon Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Interferon Sales Market Share by Application (2015-2020)
Table 74. India Interferon Sales (K Units) by Company (2015-2020)
Table 75. India Interferon Sales Market Share by Company (2015-2020)
Table 76. India Interferon Sales (K Units) by Type (2015-2020)
Table 77. India Interferon Sales Market Share by Type (2015-2020)
Table 78. India Interferon Sales (K Units) by Application (2015-2020)
Table 79. India Interferon Sales Market Share by Application (2015-2020)
Table 80. Roche Corporation Information
Table 81. Roche Description and Business Overview
Table 82. Roche Interferon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Roche Interferon Product
Table 84. Roche Recent Development
Table 85. Anke Biotechnology Corporation Information
Table 86. Anke Biotechnology Description and Business Overview
Table 87. Anke Biotechnology Interferon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Anke Biotechnology Interferon Product
Table 89. Anke Biotechnology Recent Development
Table 90. Bayer Corporation Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer Interferon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Bayer Interferon Product
Table 94. Bayer Recent Development
Table 95. Merck & Co Corporation Information
Table 96. Merck & Co Description and Business Overview
Table 97. Merck & Co Interferon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Merck & Co Interferon Product
Table 99. Merck & Co Recent Development
Table 100. Tri-Prime Corporation Information
Table 101. Tri-Prime Description and Business Overview
Table 102. Tri-Prime Interferon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Tri-Prime Interferon Product
Table 104. Tri-Prime Recent Development
Table 105. Kawin Corporation Information
Table 106. Kawin Description and Business Overview
Table 107. Kawin Interferon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Kawin Interferon Product
Table 109. Kawin Recent Development
Table 110. Genzon Pharma Corporation Information
Table 111. Genzon Pharma Description and Business Overview
Table 112. Genzon Pharma Interferon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Genzon Pharma Interferon Product
Table 114. Genzon Pharma Recent Development
Table 115. Novartis Corporation Information
Table 116. Novartis Interferon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Novartis Description and Business Overview
Table 118. Novartis Interferon Product
Table 119. Novartis Recent Development
Table 120. Biogen Corporation Information
Table 121. Biogen Interferon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Biogen Description and Business Overview
Table 123. Biogen Interferon Product
Table 124. Biogen Recent Development
Table 125. Merck KGaA Corporation Information
Table 126. Merck KGaA Description and Business Overview
Table 127. Merck KGaA Interferon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Merck KGaA Interferon Product
Table 129. Merck KGaA Recent Development
Table 130. Zydus Cadila Corporation Information
Table 131. Zydus Cadila Description and Business Overview
Table 132. Zydus Cadila Interferon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Zydus Cadila Interferon Product
Table 134. Zydus Cadila Recent Development
Table 135. Huaxin Biotechnology Corporation Information
Table 136. Huaxin Biotechnology Description and Business Overview
Table 137. Huaxin Biotechnology Interferon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Huaxin Biotechnology Interferon Product
Table 139. Huaxin Biotechnology Recent Development
Table . Harbin Pharmaceutical Corporation Information
Table . Harbin Pharmaceutical Description and Business Overview
Table . Harbin Pharmaceutical Interferon Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Harbin Pharmaceutical Interferon Product
Table . Harbin Pharmaceutical Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Interferon Distributors List
Table 148. Interferon Customers List
Table 149. Market Key Trends
Table 150. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 151. Key Challenges
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Interferon Product Picture
Figure 2. Global Interferon Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Interferon Market Share by Application in 2020 & 2026
Figure 6. Hepatitis Examples
Figure 7. Multiple Sclerosis Examples
Figure 8. Others Examples
Figure 9. Global Interferon Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Interferon Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Interferon Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Interferon Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Interferon Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Interferon Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Interferon Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Interferon Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Interferon Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Interferon Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Interferon Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Interferon Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Interferon Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Interferon Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Interferon Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Interferon Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Interferon Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Interferon Players Market Share by Revenue in Interferon 2015 & 2019
Figure 27. Interferon Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Interferon Revenue Share by Type (2015-2020)
Figure 29. Global Interferon Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Interferon Revenue Share by Application (2015-2020)
Figure 31. Global Interferon Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Interferon Sales Market Share by Type in 2019
Figure 33. United States Interferon Sales Market Share by Type in 2019
Figure 34. Europe Interferon Sales Market Share by Company in 2019
Figure 35. Europe Interferon Sales Market Share by Type in 2019
Figure 36. Europe Interferon Sales Market Share by Application in 2019
Figure 37. China Interferon Sales Market Share by Company in 2019
Figure 38. China Interferon Sales Market Share by Type in 2019
Figure 39. China Interferon Sales Market Share by Application in 2019
Figure 40. Japan Interferon Sales Market Share by Company in 2019
Figure 41. Japan Interferon Sales Market Share by Type in 2019
Figure 42. Japan Interferon Sales Market Share by Application in 2019
Figure 43. Southeast Asia Interferon Sales Market Share by Company in 2019
Figure 44. Southeast Asia Interferon Sales Market Share by Type in 2019
Figure 45. Southeast Asia Interferon Sales Market Share by Application in 2019
Figure 46. India Interferon Sales Market Share by Company in 2019
Figure 47. India Interferon Sales Market Share by Type in 2019
Figure 48. India Interferon Sales Market Share by Application in 2019
Figure 49. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Anke Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Merck & Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Tri-Prime Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Kawin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Genzon Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Biogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Zydus Cadila Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Huaxin Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Harbin Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Key Raw Materials Price Trend
Figure 63. Manufacturing Cost Structure of Interferon
Figure 64. Manufacturing Process Analysis of Interferon
Figure 65. Interferon Industrial Chain Analysis
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. Porter's Five Forces Analysis
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
インターフェロンアルファ-2aバイオシミラーの世界市場レポート2020 Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplasti…- 肝線維症治療薬の世界市場レポート2020 Liver fibrosis is the scarring process that represents the liver’s response to injury. In the same way as skin and other organs heal wounds through deposition of collagen and other matrix constituents so the liver repairs injury through the deposition of new collagen. The classification of Liver Fib…
- 生物製剤及びバイオシミラーの世界市場レポート2020 A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodi…
- 組換えグリコシル化タンパク質の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Glycosylated Protein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombinant …
- 併用療法薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Combination Therapy Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Combination Therapy …